Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

CategoryBioTech
Employees
Founded2008
Descriptionbreast cancer treatments

Offices

Funding

TOTAL $2.63M
FUNDING TOTAL $2.63M
Venture Round, 1/2009
Inveni Capital
$2.63M

Tags

OY LX Therapies

Lx Therapies, founded in 2008, is a drug discovery company focused on developing genemediated therapies for the prevention and treatment of diseases of lymphatic vasculature. The initial focus of the company is on breast cancer-related lymphoedema, a relatively common complication of breast cancer treatment for which there is currently no cure or effective treatment. Lx Therapies, based in Helsinki, has received a EUR 2 million investment from Inveni Capital, the Finnish-German life sciences venture fund and a founder of Lx Therapies.

Recent Milestones

Videos

Screenshots

Sources

  1. Ark Grants VEGF Genes Licence To Oy Lx Therapies Ltd For Lymphatic Disease (medicalnewstoday.com) [edit]
Edit This Page
Last Edited 7/2/09

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy